Dear Member,

Here is the latest newsletter from the European Society of Endocrinology ESE Advocacy Representation Scheme (EARS).

In this edition you can find further information about:

• EDCs making headlines in the face of legislative uncertainty
• European Action Plan on Rare Diseases: myth or soon a reality?
• ESE and ESPE Legacy event on Endocrine Disrupting Chemicals following the Joint Congress in May – impact report
• World Hormone Day 2026
• EURACTIV study on the role and influence of associations in Brussels
• Underspending on NCDs
• Weight loss drugs make it to WHO Essential Medicines List

Click here to read it.